A Hamid Boulares

5PUBLICATIONS
10CO-AUTHORS
PharmacogenomicsMolecular targetsInnate immunityMolecular medicineAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 09, 2022
Promotion of a synthetic degradation of activated STAT6 by PARP-1 inhibition: roles of poly(ADP-ribosyl)ation, calpains and autophagy.

Jeffrey Wang, Mohamed A Ghonim, Salome V Ibba

|Jan 26, 2021
Targeting PARP-1 with metronomic therapy modulates MDSC suppressive function and enhances anti-PD-1 immunotherapy in colon cancer.

Mohamed A Ghonim, Salome V Ibba, Abdelmetalab F Tarhuni

|Jun 11, 2019
PARP-1 Is Critical for Recruitment of Dendritic Cells to the Lung in a Mouse Model of Asthma but Dispensable for Their Differentiation and Function.

Laura C Echeverri Tirado, Mohamed A Ghonim, Jeffrey Wang

|Sep 03, 2018
Sulfated non-anticoagulant heparin blocks Th2-induced asthma by modulating the IL-4/signal transducer and activator of transcription 6/Janus kinase 1 pathway.

Mohamed A Ghonim, Jeffrey Wang, Salome V Ibba

|Aug 16, 2016
Potential of Inducible Nitric Oxide Synthase as a Therapeutic Target for Allergen-Induced Airway Hyperresponsiveness: A Critical Connection to Nitric Oxide Levels and PARP Activity.

Salome' V Ibba, Mohamed A Ghonim, Kusma Pyakurel

Pageof 1

Frequent Collaborators

1 joint publications

Salome' V Ibba

1 joint publications

Matthew R Lammi

1 joint publications

Mohamed A Ghonim

1 joint publications

Jeffrey Wang